Insulin glargine, a long-acting insulin analog, is essential in managing diabetes, providing steady glucose control over 24 hours. As diabetes cases continue to rise globally, biosimilars of insulin glargine have emerged as affordable alternatives to branded products like Sanofi’s Lantus, reducing the financial burden on healthcare systems and patients alike. Market Outlook for Insulin...

ntroduction to the Antiphospholipid Syndrome Market Antiphospholipid Syndrome (APS) is a rare autoimmune disorder that predisposes individuals to an increased risk of blood clot formation in veins and arteries, often resulting in serious complications like deep vein thrombosis (DVT), stroke, and pregnancy-related issues. As awareness and diagnostic capabilities improve, the Antiphospholipid...

In the rapidly advancing healthcare and pharmaceutical industries, success requires more than innovation—it demands strategic intelligence. DelveInsight’s Competitive Benchmarking services offer in-depth insights to help businesses analyze competitors, track industry shifts, and refine their market approach for sustainable growth. Why Competitive Benchmarking Matters Competitive...

The global pain management devices market is estimated to grow from $7.94 billion in 2024 to $13.32 billion by 2035, at a CAGR of 4.8% during the forecast period, till 2035. During our research, we were able to identify more than 30 leading players that are engaged in the pain management devices market. Majority of the leading players (80%) engaged in pain management devices market are...

An  Electronic Health Record (EHR) is a digital version of a patient’s medical history,  continuously updated by healthcare professionals. Unlike traditional paper records, EHRs combine clinical, operational, and administrative data into a unified platform that provides quick access to patient details. This digital system is key to advancing healthcare technologies,...